Personal Account
INTENSITY THERAPEUTICS, INC.

INTENSITY THERAPEUTICS, INC.

Pharmaceuticals

Company website
Open date

6/28/2023

About

Intensity Therapeutics, Inc. is a clinical-stage biotechnology company specializing in immunity against cancer. The company develops drugs based on Cisplatin, which has already demonstrated its effectiveness in preventing several types of cancer. Additionally, the company has several drugs in Phase 2 and 3 clinical trials, which presents good potential for further growth in the company's stocks.


2022 © All rights reserved

You can always come to our office to discuss any questions with our manager

Dubai

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Czech Republic, Prague, Bilkova 855/19

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.